Tang Capital
View Older Stories View More Recent Stories
-
Form SCHEDULE 13D/A Kezar Life Sciences, Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G PureTech Health plc Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13D/A Kezar Life Sciences, Filed by: TANG CAPITAL MANAGEMENT LLC
-
Aurinia to acquire Kezar Life Sciences for $6.955 per share plus CVR
-
Form SCHEDULE 13D/A Aurinia Pharmaceuticals Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13D/A Aurinia Pharmaceuticals Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A PRECISION BIOSCIENCES Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A Adicet Bio, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A Evolus, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A Keros Therapeutics, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A CytomX Therapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A Tarsus Pharmaceuticals, Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A Spyre Therapeutics, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form 13F-HR TANG CAPITAL MANAGEMENT For: Dec 31
-
Form SCHEDULE 13G/A CYBIN INC. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A Nkarta, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G CAPRICOR THERAPEUTICS, Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A ESSA Pharma Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A Bolt Biotherapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A ALX ONCOLOGY HOLDINGS Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A Compass Therapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A Bolt Biotherapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A Compass Therapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A ALX ONCOLOGY HOLDINGS Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A ESSA Pharma Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form 13F-HR TANG CAPITAL MANAGEMENT For: Sep 30
-
Form SCHEDULE 13G GALAPAGOS NV Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G Immunocore Holdings plc Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G Keros Therapeutics, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G CRESCENT BIOPHARMA, INC. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G PMV Pharmaceuticals, Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13D/A HilleVax, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13D/A iTeos Therapeutics, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form N-PX TANG CAPITAL MANAGEMENT For: Jun 30
-
Form SCHEDULE 13D/A CARGO Therapeutics, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A Compass Therapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A Elevation Oncology, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A CytomX Therapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A Bolt Biotherapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A Outlook Therapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A REVIVA PHARMACEUTICALS Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form 13F-HR TANG CAPITAL MANAGEMENT For: Jun 30
-
Form SCHEDULE 13G ESSA Pharma Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13D/A iTeos Therapeutics, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
iTeos Therapeutics (ITOS) PT Lowered to $10 at Leerink Partners
-
Form SCHEDULE 13D/A CARGO Therapeutics, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13D iTeos Therapeutics, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Citizens JMP Reiterates Market Perform Rating on Elevation Oncology (ELEV)
-
Form SCHEDULE 13D/A ACELYRIN, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13D/A Allakos Inc. Filed by: TANG CAPITAL MANAGEMENT LLC

